SRF Q2 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
See what SRF management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what SRF management said on order book — free account, 30 seconds.
Capex plans
Track SRF — get its next earnings analysis in your feed
Margin guidance
Order book
How does SRF rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does SRF rank in Chemicals & Petrochemicals?
Compare SRF against every Chemicals & Petrochemicals company (Q2 FY24) on revenue, margins and earnings-call signals.
Continue your research
What SRF's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Sudarshan Chemical Industries Ltd (Q1 FY27)
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
- Indo Borax & Ch. (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
- Deepak Fertilis. (Q1 FY27)
Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…
- Sudarshan Chemical Industries Ltd (Q1 FY27)
Volume growth has been modest (~6% in Q1), with confidence rooted in business recovery and value capture initiatives (Page 6). Key concall takeaways from…